Literature DB >> 22419584

Estimation and variable selection via frailty models with penalized likelihood.

E Androulakis1, C Koukouvinos, F Vonta.   

Abstract

The penalized likelihood methodology has been consistently demonstrated to be an attractive shrinkage and selection method. It does not only automatically and consistently select the important variables but also produces estimators that are as efficient as the oracle estimator. In this paper, we apply this approach to a general likelihood function for data organized in clusters, which corresponds to a class of frailty models, which includes the Cox model and the Gamma frailty model as special cases. Our aim was to provide practitioners in the medical or reliability field with options other than the Gamma frailty model, which has been extensively studied because of its mathematical convenience. We illustrate the penalized likelihood methodology for frailty models through simulations and real data.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22419584     DOI: 10.1002/sim.5325

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Selection of effects in Cox frailty models by regularization methods.

Authors:  Andreas Groll; Trevor Hastie; Gerhard Tutz
Journal:  Biometrics       Date:  2017-01-13       Impact factor: 2.571

2.  Variable selection in discrete survival models including heterogeneity.

Authors:  Andreas Groll; Gerhard Tutz
Journal:  Lifetime Data Anal       Date:  2016-03-14       Impact factor: 1.588

3.  Variable selection in subdistribution hazard frailty models with competing risks data.

Authors:  Il Do Ha; Minjung Lee; Seungyoung Oh; Jong-Hyeon Jeong; Richard Sylvester; Youngjo Lee
Journal:  Stat Med       Date:  2014-07-10       Impact factor: 2.373

4.  A dual frailty model for lifetime analysis in maritime transportation.

Authors:  Robin Henderson; Ralitsa Mihaylova; Paul Oman
Journal:  Lifetime Data Anal       Date:  2019-02-19       Impact factor: 1.588

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.